DNA encoding a novel RG1 polypeptide
US6682902B2 · kind B2 · utility
7Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2000 |
| Grant date | Jan 27, 2004 |
| Priority date | — |
| Expiry date | Aug 8, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel human extracellular matrix polypeptides, designated RG1, polynucleotides encoding the polypeptides, methods for producing the polypeptides, expression vectors and genetically engineered host cells for expression of the polypeptides. The invention further relates to methods for utilizing the polynucleotides and polypeptides in research, diagnosis, and therapeutic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.